In dogs, mast cell tumors are the most common malignant skin tumors, accounting for approximately 16–21% of all skin cancers. These tumors can appear anywhere on the body but are most frequently found ...

Canine mast cell tumours (MCTs) represent one of the most prevalent neoplasms in dogs, characterised by their markedly heterogeneous clinical behaviour. These tumours, ranging from benign lesions to ...

Scientists have presented a new approach to cancer treatment using mast cells, which are immune cells known for their ability ...

Systemic mastocytosis (SM) is a rare blood disorder in which the body produces too many mast cells. Part of the immune response, mast cells are a type of white blood cell that releases histamine in ...

Blueprint Medicines’ focus on Ayvakit continues to pay off, which has ample untapped revenue potential in advanced and indolent systemic mastocytosis. Additionally, their pipeline includes other ...

Allakos is a clinical stage biotechnology company developing therapeutics which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative ...

A new study published in the International Journal of General Medicine showed that by focusing on mast cells and inflammatory ...

– Atopic dermatitis and prurigo nodularis skin lesions show evidence of MRGPRX2 mast cell activation and activated macrophages – – AK006 inhibited mast cell activation and reduced mast cell numbers in ...